Annual CFO
-$1.11 M
-$15.43 M-107.77%
01 December 2023
Summary:
Opus Genetics annual cash flow from operations is currently -$1.11 million, with the most recent change of -$15.43 million (-107.77%) on 01 December 2023. During the last 3 years, it has risen by +$5.68 million (+83.64%).IRD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$5.13 M
+$2.16 M+29.65%
01 September 2024
Summary:
Opus Genetics quarterly cash flow from operations is currently -$5.13 million, with the most recent change of +$2.16 million (+29.65%) on 01 September 2024. Over the past year, it has dropped by -$2.13 million (-70.83%).IRD Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$13.59 M
-$2.13 M-18.56%
01 September 2024
Summary:
Opus Genetics TTM cash flow from operations is currently -$13.59 million, with the most recent change of -$2.13 million (-18.56%) on 01 September 2024. Over the past year, it has dropped by -$36.72 million (-158.75%).IRD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IRD Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -107.8% | -70.8% | -158.8% |
| 3 y3 years | +83.6% | -43.1% | +24.8% |
| 5 y5 years | - | - | - |
IRD Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -107.8% | -117.8% | -158.8% |
Opus Genetics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.13 M(-29.6%) | -$13.59 M(+18.6%) |
| June 2024 | - | -$7.29 M(+27.6%) | -$11.46 M(+260.2%) |
| Mar 2024 | - | -$5.72 M(-225.7%) | -$3.18 M(+186.2%) |
| Dec 2023 | -$1.11 M(-107.8%) | $4.55 M(-251.4%) | -$1.11 M(-104.8%) |
| Sept 2023 | - | -$3.00 M(-403.6%) | $23.13 M(+6.9%) |
| June 2023 | - | $989.00 K(-127.1%) | $21.64 M(+28.5%) |
| Mar 2023 | - | -$3.65 M(-112.7%) | $16.84 M(+17.6%) |
| Dec 2022 | $14.31 M | $28.79 M(-740.1%) | $14.31 M(-171.1%) |
| Sept 2022 | - | -$4.50 M(+18.1%) | -$20.12 M(+4.8%) |
| June 2022 | - | -$3.81 M(-38.3%) | -$19.21 M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$6.17 M(+9.3%) | -$19.73 M(+1.8%) |
| Dec 2021 | -$19.37 M(+185.0%) | -$5.65 M(+57.5%) | -$19.37 M(+7.1%) |
| Sept 2021 | - | -$3.58 M(-17.2%) | -$18.08 M(+16.3%) |
| June 2021 | - | -$4.33 M(-25.5%) | -$15.55 M(+31.0%) |
| Mar 2021 | - | -$5.81 M(+33.4%) | -$11.88 M(+74.7%) |
| Dec 2020 | -$6.80 M(+89.2%) | -$4.36 M(+312.7%) | -$6.80 M(+178.7%) |
| Sept 2020 | - | -$1.06 M(+62.2%) | -$2.44 M(+76.4%) |
| June 2020 | - | -$651.00 K(-11.1%) | -$1.38 M(+88.9%) |
| Mar 2020 | - | -$732.00 K | -$732.00 K |
| Dec 2019 | -$3.59 M | - | - |
FAQ
- What is Opus Genetics annual cash flow from operations?
- What is the all time high annual CFO for Opus Genetics?
- What is Opus Genetics annual CFO year-on-year change?
- What is Opus Genetics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Opus Genetics?
- What is Opus Genetics quarterly CFO year-on-year change?
- What is Opus Genetics TTM cash flow from operations?
- What is the all time high TTM CFO for Opus Genetics?
- What is Opus Genetics TTM CFO year-on-year change?
What is Opus Genetics annual cash flow from operations?
The current annual CFO of IRD is -$1.11 M
What is the all time high annual CFO for Opus Genetics?
Opus Genetics all-time high annual cash flow from operations is $14.31 M
What is Opus Genetics annual CFO year-on-year change?
Over the past year, IRD annual cash flow from operations has changed by -$15.43 M (-107.77%)
What is Opus Genetics quarterly cash flow from operations?
The current quarterly CFO of IRD is -$5.13 M
What is the all time high quarterly CFO for Opus Genetics?
Opus Genetics all-time high quarterly cash flow from operations is $28.79 M
What is Opus Genetics quarterly CFO year-on-year change?
Over the past year, IRD quarterly cash flow from operations has changed by -$2.13 M (-70.83%)
What is Opus Genetics TTM cash flow from operations?
The current TTM CFO of IRD is -$13.59 M
What is the all time high TTM CFO for Opus Genetics?
Opus Genetics all-time high TTM cash flow from operations is $23.13 M
What is Opus Genetics TTM CFO year-on-year change?
Over the past year, IRD TTM cash flow from operations has changed by -$36.72 M (-158.75%)